Mar 26 |
Precision BioSciences Q4 Earnings Preview
|
Mar 20 |
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
|
Mar 19 |
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy
|
Mar 6 |
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
|
Mar 1 |
Precision BioSciences stock falls after pricing $40M securities offering
|
Mar 1 |
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
|
Feb 29 |
Precision BioSciences announces proposed public offering of common stock and warrants
|
Feb 29 |
Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
|
Feb 27 |
Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?
|
Feb 20 |
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
|